홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Olsalazine

HCID 22419
새 반응
인쇄
기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
15722-48-2
표준 SMILES
O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O
InChIKey
QQBDLJCYGRGAKP-UHFFFAOYSA-N
분자식
C14H10N2O6
평균 분자량
302.24 g/mol
단동위원소 질량
302.05388604

개요

Olsalazine is an azobenzene that consists of two molecules of 4-aminosalicylic acid joined by an azo linkage. A prodrug for mesalazine, an anti-inflammatory drug, it is used (as the disodium salt) in the treatment of inflammatory bowel disease. It has a role as a non-steroidal anti-inflammatory drug and a prodrug. It is a member of azobenzenes and a dicarboxylic acid. It is functionally related to a salicylic acid. It is a conjugate acid of an olsalazine(2-).

이름 및 식별자

우선 이름
Olsalazine
IUPAC
5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid
영어명
OLSALAZINE
분자식
C14H10N2O6
분자량
302.24

이름 및 동의어

Olsalazine15722-48-2OlsalazinaOlsalazinumDipentumRasal5,5'-Azobis(salicylic acid)3,3'-Azobis(6-hydroxybenzoic acid)Salicylic acid, 5,5'-azodi-C. i. mordant yellow 5OLSALAZINE [INN]Azodisal
이름 더 보기
Ph-CJ-91BDipentiumOlsalazine D6Olsalazine-13C6Olsalazine 13C12c.i.mordantyellow5OLSALAZINE USP/EP/BPOLSALAZINE 15722-48-2
5,5'-azodisalicylic acidULS5I8J03O5,5'-(diazene-1,2-diyl)bis(2-hydroxybenzoic acid)Benzoic acid, 3,3'-azobis(6-hydroxy-(E)-5,5'-(diazene-1,2-diyl)bis(2-hydroxybenzoic acid)CHEBI:7770DTXSID80233915-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid

데이터베이스 식별자

CAS
15722-48-2
PubChem CID
22419
DTXSID
DTXSID8023391
ChEMBL
CHEMBL425
ChEBI
CHEBI:7770
UNII
ULS5I8J03O

물성

구조 계산 물성

XLogP
3.1
극성 표면적
140 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
8
회전 가능 결합 수
4
무거운 원자 수
22
형식 전하
0
복잡도
415

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsPharmaceuticals

물리화학적 성질

녹는점
300 °C · >300 °C(Solv: acetic acid (64-19-7); water (7732-18-5))
끓는 점
443.29 °C · 443.29°C (rough estimate)
밀도
1.3578 · 1.3578 (rough estimate)
굴절률
1.65 · 1.6500 (estimate)
용해도
DMSO: solubleMethanol: soluble
물리적 상태
Solid
산도 계수 (pKa)
2.4 · 2.40±0.10(Predicted)
색상
Light yellow to yellow
수용성
11.49 ug/L · 11.49ug/L(25℃)

화학 및 산업

약리 정보

Protein Binding · 1건

Olsalazine and its metabolite olsalazine-S, are more than 99% bound to plasma proteins. Less than 1% of both olsalazine and olsalazine-S appears undissociated in plasma. It does not interfere with the protein binding of warfarin. Mesalamine (5-aminosalicylic acid, 5-ASA) and its metabolite, N-acetyl-5-ASA, are 74 and 81%, respectively, bound to plasma proteins.

Pharmacodynamics · 1건

Olsalazine is an anti-inflammatory agent that blocks the production of cyclooxygenase (COX)-derived products of arachidonic acid metabolism. It works to alleviate inflammation in ulcerative colitis. Olsalazine was shown to decrease water and sodium absorption. While olsalazine is not expected to affect the motility and transit time of small intestines, it decreased small bowel transit time at high doses ranging from 60 to 120 mg/kg. In about 40% of the patients with ulcerative colitis, administration of olsalazine 1g daily was associated with a decrease in whole gut transit time.

Mechanism of Action · 1건

Upon administration, the azo bond connecting two molecules of mesalamine (also known as 5-aminosalicylic acid or 5-ASA) is cleaved by azoreductase-containing bacteria in the colon. The two molecules of mesalamine are released to mediate therapeutic effects. The exact mechanism of action of olsalazine and its active moiety mesalamine in ulcerative colitis has not been elucidated; however, it is understood that mesalamine mediates an anti-inflammatory action on epithelial cells of the colon. The COX-derived (i.e., prostanoids such as prostaglandin E2) and lipoxygenase-derived products (i.e., leukotrienes [LTs] and hydroxyeicosatetraenoic acids [HETEs]) of arachidonic acid metabolism have been implicated in the pathogenesis and maintenance of inflammatory disorders, including ulcerative colitis and inflammatory bowel disease. Mesalamine may attenuate inflammation by blocking the COX enzyme and inhibiting prostaglandin production in the colon. Olsalazine was also shown to inhibit xanthine oxidase, an enzyme that generates oxygen-derived free radicals. Olsalazine may attenuate intestinal inflammation by limiting macrophage migration to inflamed intestinal mucosa: it was shown to inhibit _in vitro_ migration of intestinal macrophages in response to leukotriene B<sub>4</sub>. Olsalazine may also act as a free radical scavenger, and mesalazine may suppress fatty acid peroxidation.

관련 반응

4건
반응 기록 만들기
HRID 1750338 반응식
HRID 1750338반응물로
HRID 2202207 반응식
HRID 2202207반응물로
HRID 2205960 반응식
HRID 2205960반응물로
HRID 2272552 반응식
HRID 2272552반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
Nikkaji
J227.692E
Biological Half-LifeOlsalazine has a very short serum half-life, approximately 0.9 hours. Olsalazine-S has a half-life of seven days due to slow dissociation from the protein binding site.
Metabolism/Metabolites · 1건

Olsalazine is cleaved by colonic bacteria to release its active ingredient, mesalamine. Mesalamine can undergo acetylation to form N-acetyl-5-aminosalicylic acid (N-acetyl-5-ASA, Ac-5-ASA) by the colonic epithelium; however, the extent of acetylation depends on transit time. Approximately 0.1% of an oral dose of olsalazine is metabolized in the liver to olsalazine-O-sulfate (olsalazine-S).

Absorption, Distribution and Excretion · 3건

After oral administration, olsalazine has limited systemic bioavailability, with less than 5% of the oral dose being absorbed. Based on oral and intravenous dosing studies, approximately 2.4% of a single 1 g oral dose is absorbed. Maximum serum concentrations of olsalazine appear after approximately one hour and, even after a 1 g single dose, are low (e.g., 1.6 to 6.2 µmol/L). Patients on daily doses of 1 g olsalazine for two to four years show a stable plasma concentration of olsalazine-S (3.3 to 12.4 µmol/L). Olsalazine-S accumulates to a steady state within two to three weeks. Serum concentrations of mesalamine are detected after four to eight hours. The peak levels of mesalamine after an oral dose of 1 g olsalazine are low (i.e., 0 to 4.3 µmol/L).

Olsalazine and its metabolites are excreted in the urine. Total recovery of oral 14C-labeled olsalazine in animals and humans ranges from 90 to 97%. Approximately 20% of the total mesalamine is recovered in the urine. Of the total mesalamine found in the urine, more than 90% is N-acetyl-5-ASA. Only small amounts of mesalamine are detected in the urine. The remaining mesalamine is partially acetylated and excreted in the feces. From fecal dialysis, the concentration of mesalamine in the colon following olsalazine has been calculated to be 18 to 49 mmol/L. The urinary recovery of olsalazine is below 1%. Less than 5% of an oral dose (0.25 to 2g) was recovered unchanged in the feces; however, more than 50% of the oral dose was excreted in feces as unchanged olsalazine when the whole gut transit time was decreased by approximately 50%.

The steady-state volume of distribution determined in healthy volunteers is approximately 5L.

용도 및 제조

Use ClassificationPharmaceuticals

응용 분야

용도Anti-inflammatory (gastrointestinal).

상·하류 제품 정보

상류 원료

살리실산메탄설포닐 클로라이드메틸5-니트로살리실레이트Mesalazine Ethyl Esterolsalazine methyl esterMETHYL5-아미노살리실레이트살리실산 메틸2-클로로-5-니트로 벤조익 산5-아미노셀릭일 산

추가 설명

정의ChEBI: An azobenzene that consists of two molecules of 4-aminosalicylic acid joined by an azo linkage. A prodrug for mesalazine, an anti-inflammatory drug, it is used (as the disodium salt) in the treatment of inflammatory bowel disease.